Evaluating the Effectiveness of Print Based Environmental Health Intervention Education Among Sch… (NCT07379983) | Clinical Trial Compass
CompletedPhase 4
Evaluating the Effectiveness of Print Based Environmental Health Intervention Education Among School Going Adolescents of Karachi, A Quasi Study
Pakistan500 participantsStarted 2026-01-19
Plain-language summary
This study investigates the impact of school-based educational interventions on adolescents' knowledge and practices related to environmental health in Karachi, Pakistan. The methodology opted for this research is quasi experiment with three months intervention period. The research will begin with a baseline survey to assess adolescents' understanding of environmental health, green spaces, waste management, and associated health impacts. Schools are then engaged in creating and maintaining green spaces and adopting waste management practices. Two intervention arms are implemented: Arm 1 receives educational content through posters, while Arm 2 receives pamphlets. In March, schools are revisited to evaluate the maintenance of cleanliness and green spaces. Finally, in April, a post-intervention survey will be conducted to measure changes in knowledge and eco-friendly practices. The study aims to determine the effectiveness of posters versus pamphlets in enhancing knowledge and sustaining environmental practices among adolescents, thereby contributing to evidence-based strategies for promoting environmental health education in urban school settings.
Who can participate
Age range
10 Years – 16 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* The study will target only one mode of education in Karachi, i.e., the matriculation system, including both public and private schools to cover a broad segment of the adolescent student population.
* Schools registered with the Board of Secondary Education Karachi (BSEK) will be included, ensuring that students from both sectors will follow the same curriculum.
* Schools must have at least 30 students in each class from 6th to 10th grade, so that each class can serve as a stratum.
* Only schools that provide permission to conduct the study within their premises will be enrolled.
* Only students who provide assent and whose parents provide consent will be included
Exclusion Criteria:
* Any participant who plans to leave their school during the study period.
* Any participant who is not present during any round of the study, i.e., before and after the intervention.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.